T-bet controls severity of hypersensitivity pneumonitis by Abdelsamed, Hossam Aly et al.
RESEARCH Open Access
T-bet controls severity of hypersensitivity
pneumonitis
Hossam Aly Abdelsamed, Meena Desai, Stephanie C Nance and Elizabeth A Fitzpatrick
*
Abstract
Hypersensitivity Pneumonitis (HP) is an interstitial lung disease that develops following repeated exposure to
inhaled environmental antigens. The disease is characterized by alveolitis, granuloma formation and in some
patients’ fibrosis. IFNg plays a critical role in HP; in the absence of IFNg granuloma formation does not occur.
However, recent studies using animal models of HP have suggested that HP is a Th17 disease calling into question
the role of IFNg. In this study, we report that initially IFNg production is dependent on IL-18 and the transcription
factor T-bet, however as the disease continues IFNg production is IL-18-independent and partially T-bet dependent.
Although IFNg production is required for granuloma formation its role is distinct from that of T-bet. Mice that are
deficient in T-bet and exposed to S. rectivirgula develop more severe disease characterized by an exacerbated Th17
cell response, decreased Th1 cell response, and increased collagen production in the lung. T-bet-mediated
protection does not appear to be due to the development of a protective Th1 response; shifting the balance from
a Th17 predominant response to a Th1 response by inhibition of IL-6 also results in lung pathology. The results
from this study suggest that both Th1 and Th17 cells can be pathogenic in this model and that IFNg and T-bet
play divergent roles in the disease process.
Background
Hypersensitivity Pneumonitis (HP) or extrinsic allergic
alveolitis is an interstitial lung disease that develops fol-
lowing repeated exposure to inhaled environmental anti-
gens [1-3]. The disease is characterized by alveolitis and
granuloma formation and with continued exposure to
the inciting agent some patients develop chronic irrever-
sible fibrosis. Once a patient progresses to the chronic
form of the disease the long-term prognosis is poor.
Although many individuals are exposed to these envir-
onmental antigens only approximately 5-15% of the
exposed population will develop disease [1,4]. The low
prevalence rate suggests that environmental and/or host
genetic co-factors contribute to development of disease.
In addition, there is considerable variability in disease
severity and response to treatment in patients that
develop HP demonstrating the complexity of the disease
[reviewed in (5)].
Farmers Lung Disease is one of the most common
types of HP and is caused by repeated inhalation of the
thermophile Saccharopolyspora rectivirgula,w h i c hi s
commonly found in moldy hay. The animal model used
to study Farmers Lung disease is the well-characterized
S. rectivirgula mouse model [6-9]. Mice intranasally
inoculated with S. rectivirgula for 3 days/week for 3
weeks develop an alveolitis that is initially neutrophilic
but becomes more lymphocytic upon subsequent expo-
sures. By the third week of exposures granulomas
develop composed of macrophages and T cells sur-
rounded by fibroblasts. The development of granulomas
is dependent on CD4
+ T cells; athymic nude mice do
not develop disease and CD4
+ T cells from sensitized
mice can adoptively transfer disease to naïve recipients
[10-12]. The disease is dependent on IFNg;I F N g knock-
out (KO) mice exposed to S. rectivirgula develop alveoli-
tis but not granulomas nor the subsequent fibrotic
response [13,14]. Together, these results led to the sug-
gestion that HP was mediated by pathogenic Th1 cells.
However, some anomalies exist suggesting that HP is a
much more complex disease. Previous studies in our lab
demonstrated that innate immune cell IFNg production
is sufficient for granuloma formation following exposure
to S. rectivirgula and T cell IFNg production is not
necessary [15]. Recent studies have found that IL-17 is
associated with disease severity suggesting that the Th17
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the disease. Exposure of IL-17ra
-/- mice to S. rectivirgula
resulted in decreased inflammation and fibrosis com-
pared to WT mice suggesting a pivotal role for Th17
cells and IL-17 in the disease process [16]. These results
call into question the role of IFNg and Th1 cells in dis-
ease pathogenesis in this model. IFNg is a critical media-
tor of the immune response, responsible for activating
macrophages, stimulating pro-inflammatory cytokines,
chemokines, and adhesion molecules, and differentiation
of Th1 cells. IFNg also appears to play a role in regulat-
ing the IL-17 response; studies using murine arthritis
models have demonstrated that IFNg suppresses IL-17
production and regulates the outcome of a Th1 vs Th17
response [17-19]. The absence of IFNg during HP,
results in decreased granuloma formation which would
not be expected if IFNg was acting by inhibiting the
pathogenic Th17 response. These results suggest that
IFNg plays a role in the disease process other than regu-
lation of IL-17 and the Th17 response in HP. Many of
the effects of IFNg are mediated through induction of
T-bet which is the major transcription factor regulating
IFNg production. Therefore, stimulation of T-bet
expression by IFNg results in a positive feedback loop
that makes it difficult to distinguish the individual con-
tributions of T-bet and IFNg to a disease process.
The goal of the present study was to identify the fac-
tors involved in regulation of IFNg during HP and deter-
mine whether the effects of IFNg were mediated by T-
b e t .T h er e s u l t ss h o wt h a td u r i n gt h ei n n a t ei m m u n e
response to S. rectivirgula,I F N g production is depen-
dent on IL-18 and T-bet, whereas during later phases
IFNg production was IL-18-independent and partially T-
bet dependent. Although IFNg production is required
for granuloma formation its role is distinct from that of
T-bet. Mice that are deficient in T-bet and exposed to
S. rectivirgula develop more severe disease characterized
by an exacerbated Th17 cell response, decreased Th1
cell response, and increasedc o l l a g e np r o d u c t i o ni nt h e
lung. T-bet-mediated protection does not appear to be
due to the development of a protective Th1 response;
shifting the balance from a Th17 predominant response
to a Th1 response by inhibition of IL-6 also results in
lung pathology. The results from this study suggest that
both Th1 and Th17 cells can be pathogenic in this
model and that IFNg and T-bet play divergent roles in
the disease process.
Methods
Animals and S. rectivirgula exposure protocol
C57BL/6, IL-18
-/- and T-bet
-/- female mice were pur-
chased from Jackson Laboratories (Bar Harbor, ME) at 6
weeks of age. All animals were housed in sterile micro-
isolator cages with sterile food and water ad libitum and
were maintained by the Division of Comparative Medi-
cine at the University of Tennessee Health Science Cen-
ter according to the guidelines of the Animal Welfare
Act. The institutional animal care and use committee
approved all experimental procedures. The S. rectivir-
gula (strain designation A1313 - ATCC) preparation
was grown at 55°C in trypticase soy broth. The bacterial
preparation was washed in endotoxin free distilled water
3 times followed by sonication and lyophilization. The
lyophilized preparation was reconstituted with endo-
toxin free saline.
BAL and lung cell isolation
Mice were anesthetized with isoflurane and intranasally
inoculated with the indicated amount of S. rectivirgula
for 3 days/week for 3 weeks. Bronchoalveolar lavage
(BAL) was performed by intranasal injection of 1 ml of
PBS into the lungs with immediate vacuum aspiration.
The amount of fluid recovered was routinely around
70%. Cells were recovered from BAL fluid (BALF) by
centrifugation and counted using trypan blue dye exclu-
sion. The BALF was frozen at -80 until used in ELISA
assays for cytokine and chemokine measurement. Lungs
were perfused with phosphate-buffered saline (PBS) to
remove blood and both lobes removed. Lung tissue was
digested with collagenase (20 U/ml) and deoxyribonu-
clease I (40 μg/ml) for 60 minutes at 37°C. Cells were
freed by disruption in a Stomacher tissue processor and
then isolated by centrifugation on a discontinuous per-
coll gradient. Mononuclear cells were isolated at the 40/
80% interface following density gradient centrifugation
and used in flow cytometry.
Flow Cytometry
Flow cytometry was performed on isolated BAL and
lung cells using fluorochrome-conjugated antibodies to
CD11b, Gr1, CD45, CD4, CD8, bTcR chain, and NK1.1
(BD Biosciences, San Jose, CA or ebiosciences, San
Diego, CA). For neutrophil cell sorting, lung cells from
mice were pooled and incubated with antibodies to
CD45, Ly6G, CD11b, and NK1.1. The stained cells were
sorted on a BD FACSAria and neutrophils were identi-
fied as CD45
+/Ly6G
+/CD1b
+/NK1.1
-. For intracellular
cytokine staining, lung cells were prepared from indivi-
dual mice and enriched for lymphocytes by removing
adherent cells, and then incubated overnight with S. rec-
tivirgula (5 μg) in the presence of splenic adherent cells
from unexposed WT mice. The next day golgi plug (BD
Biosciences) was added for 5 hrs prior to staining for
flow cytometry. Some lung cells were stimulated with
PMA and ionomycin for 5 hrs instead of S. rectivirgula.
Cells were stained with antibody to IFNg,I L - 1 7 ,o ri s o -
type control antibody. A minimum of 50,000 events/
sample was collected on a BD Biosciences LSRII
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cell surface markers and intracellular cytokines was ana-
lyzed using DIVA software.
Histology
The left lobe of lung was removed and fixed with neu-
tral buffered formalin and embedded in paraffin. Eight
micron sections were cut and stained with Hematoxylin
and Eosin (H&E) to analyze granuloma formation.
Collagen Content
The collagen content from the right lung lobe was
determined using the Sircoll collagen assay (Biocolor,
UK) as per manufacturer’s instructions. Briefly, one
lung lobe was homogenized in 0.5 M acetic acid con-
taining protease inhibitors and incubated for 24 hrs at
4 C. The homogenate was centrifuged and 100 μlo f
the supernatant was incubated with the Sirius red dye
reagent. The suspension was centrifuged, excess Sirius
red dye reagent was aspirated off, and the pellet was
resuspended in 0.5 M NaOH. The samples and col-
lagen standards were read at 540 nm on a spectrophot-
ometer. The collagen content was calculated using a
standard curve generated using known concentrations
of collagen.
ELISA
Cytokines present in unconcentrated BALF were mea-
sured by ELISA (ebiosciences) according to manufac-
turer’s instructions. Cytokine standards ranging from 3.2
pg/ml to 10,000 pg/ml were prepared to determine the
concentration of cytokine in the samples. For data ana-
lysis, a curve fit was applied to the standards and the
sample concentrations extrapolated from the standard
curve using four-parameter logistic software (SoftMax
Pro, Sunnyvale, CA).
Real-time PCR
Total RNA was extracted from the upper right lobe of
lung from individual mice using TRIZOL (Invitrogen).
Contaminating genomic DNA was removed by treat-
ment with DNA-free (Ambion, Austin, TX) according to
manufacturers’ directions. One μgo fR N Aw a sr e v e r s e
transcribed into cDNA with the Transcriptor First
Strand cDNA Synthesis Kit (Roche Applied Science,
Indianapolis). Real-time PCR was performed on a Light-
cycler
®480 Real-Time PCR system (Roche Applied
Science). Relative quantities of mRNA were determined
using the Lightcycler
®480 Probes Master mix and the
comparative threshold cycle method. Primer sequences
were designed using ProbeFinder software (Roche
Applied Science) and probes chosen from the Universal
Probe Library. mRNA levels for each gene were normal-
ized to hypoxanthine guanine phosphoribosyl transferase
(HGRT) and the fold increase in signal over controls
was determined by the ΔΔct calculation.
Statistics
Results are expressed as mean +/- S.D. Data were ana-
lyzed using One-way ANOVA or Student’s t-test using
GraphPad Prism statistical software (GraphPad Software,
San Diego, CA). Differences were considered significant
at P values of less than 0.05.
Results
T-bet and IL-18 contribute to IFNg production during
innate immune response
Previous studies in our lab demonstrated that neutro-
phils produce IFNg during the initial phase of HP and
we sought to identify the cytokines responsible for sti-
mulating neutrophil IFNg production. Neutrophils from
the lungs of mice previously exposed to S. rectivirgula
were sorted and stimulated in vitro with IL-12, IL-15, or
IL-18 alone and in combination, and IFNg in cell culture
supernatants was measured by ELISA (Figure 1A). Neu-
trophils did not produce IFNg to any of the cytokines
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Figure 1 Role of IL-18 and T-bet in IFNg production in vitro. A.)
Neutrophils (CD45
+/CD11b
+/Ly6G
+/NK1.1
-) were sorted from the
lungs of WT mice exposed to S. rectivirgula one time. The cells were
stimulated overnight with IL-12 (10 ng/ml), IL-15 (20 ng/ml) or IL-18
(20 ng/ml) alone or in combination. Culture supernatants were
collected and IFNg measured by ELISA. B.) Spleen cells were isolated
from WT or T-bet-/- mice and stimulated overnight with S.
rectivirgula (10 μg); IFNg was measured in cell culture supernatants
by ELISA.
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either IL-12 or IL-15, significant IFNg production was
measured. The combination of IL-12 and IL-15 did not
stimulate IFNg production by neutrophils, suggesting
that IL-18 was necessary for its production. IL-18 stimu-
lates IFNg production through the transcription factor T-
bet [20,21] and we sought to determine whether S. recti-
virgula stimulation of IFNg production was also T-bet
dependent. We stimulated spleen cells from C57Bl/6
(WT) or T-bet KO mice with S. rectivirgula and mea-
sured IFNg production in the culture supernatants by
ELISA (Figure 1B). The results demonstrate that S. recti-
virgula stimulates large amounts of IFNg from WT cells
that is completely dependent on T-bet; cells from T-bet
KO mice produced significantly less IFNg compared to
WT cells following stimulation. Taken together, these in
vitro results suggested to us that both T-bet and IL-18
m i g h tp l a yar o l ei nI F N g production during HP. To
determine the role of T-bet and IL-18 in IFNg production
in vivo we exposed WT, T-bet
-/- and IL-18
-/- mice to
three exposures of S. rectivirgula and measured cytokine
production in the lungs. The results demonstrate that
following exposure, WT and IL-18
-/- mice develop simi-
lar levels of alveolitis whereas T-bet
-/- mice developed a
less severe alveolitis (Table 1). The overall cellular com-
position of the alveolitis was similar between all the
groups with the exception of NK cells which were signifi-
cantly reduced in the BALF from T-bet
-/- mice. Real time
PCR was used to measure cytokine production in the
lungs following exposure and the results reveal that in
comparison to WT mice IFNg mRNA is reduced in both
the IL-18
-/- and T-bet
-/- groups (Figure 2A). In addition
we could only detect IFNg in the BALF of 1/5 T-bet
-/-
mice compared to the WT group which had detectable
IFNg (Figure 2B). Surprisingly, there was also a reduction
in the level of IL-17mRNA in both the T-bet
-/- and IL-
18
-/- mice compared to WT mice. IL-17 stimulates MIP-
2 production which in turn stimulates neutrophil recruit-
ment. However, despite the decreased alveolitis in T-
bet
-/- mice, the levels of MIP-2 mRNA, which is strongly
induced in HP, was similar to IL-18
-/- and WT mice
exposed to S. rectivirgula. These results suggest that both
IL-18 and T-bet play a role in IFNg production during
the innate immune response to S. rectivirgula.
T-bet inhibits development of Th17 response
Many of the effects of IFNg are mediated by the tran-
scription factor T-bet. T-bet is critical for differentiation
of Th1 cells, Th1 cell migration through induction of
the chemokine receptor CXCR3, and has been reported
to inhibit the development of a Th17 response [22-24].
To determine the role of T-bet in the disease, WT or
T-bet
-/- mice were exposed to S. rectivirgula and ana-
lyzed for the development of HP at 3 and 6 weeks. T-
bet
-/- mice developed a less severe alveolitis compared
to WT mice with 6 weeks of S. rectivirgula exposure
(Table 2). The cellular composition of the BALF in the
Table 1 T-bet
-/- mice develop less severe alveolitis compared to WT and IL-18
-/- mice following exposure to S.
Rectivirgula
Alveolitis
a %PMN
b Total PMN
b (% +/- SD) Total NK
b (+/-SD)
WT/unexp 0.09 × 10
6+/-0.04 - - -
WT/S. rectivirgula 1.5 × 10
6+/-0.8 73+/-5 1.1 × 10
6+/-0.5 2.03 × 10
4+/-0.7
Tbet
-/- /S. rectivirgula 0.5 × 10
6+/-0.3 * 66+/-10 0.4 × 10
6+/-0.2 * 0.05 × 10
4+/-0.07 *
IL-18
-/- /S. rectivirgula 1.3 × 10
6+/-0.6 78+/-3 1.0 × 10
6+/-0.5 4.1 × 10
4+/-2.0
C57BL/6, IL-18
-/- or T bet
-/- mice (n = 5/group) were exposed to S. rectivirgula (150 μg) three times and analyzed 18 hrs after last exposure.
a BAL was performed and the recovered cells were counted using trypan blue dye exclusion.
b Cells isolated from the BAL fluid were incubated with antibodies to various cell surface markers and analyzed by flow cytometry to determine the cellular
composition of the BALF. PMNs were identified as: CD45
+/CD11b
+/Gr1
+; NK cells as CD45
+/NK1.1
+
* p < 0.05 compared to WT/S. rectivirgula group.
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Figure 2 IFNg and IL-17 mRNA are decreased in T-bet
-/- and IL-
18R
-/- mice following S. rectivirgula exposure. C57BL/6, IL-18-/-,
or T-bet-/- mice (5/group) were intranasally exposed to S. rectivirgula
(150 μg) or saline for 3 days. A.) RNA was isolated from lungs of
individual mice, reverse transcribed, and real-time PCR performed
using primers specific for MIP-2, IFNg and IL-17. The results were
normalized to the housekeeping gene HPRT and expressed as fold
induction over unexposed mice. B.) IFNg was measured in the BALF
of individual mice by ELISA.
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-/- mice was similar with the exception of
NK cells which were significantly decreased in the T-
bet
-/- mice at 3 weeks; with 6 weeks of S. rectivirgula
exposures the % of NK cells (and total number) in the
BALF of WT mice is below 1%. The IL-18
-/- mice did
not differ from the WT mice following S. rectivirgula
exposure for any of the parameters analyzed (data not
shown).
To examine the effect of T-bet on CD4+ T cell migra-
tion into the lung flow cytometry was performed. There
was no difference in the percentage of CD4+ T cells that
entered the lungs of WT and T-bet
-/- exposed mice (WT/
SR = 64%+/-5 vs T-bet
-/-/SR = 69%+/-6). However, there
was significantly less CD4+ T cells expressing the chemo-
kine receptor CXCR3, which is induced by T-bet, in the
lungs of the T-bet
-/- mice compared to WT mice (WT/SR
= 28%+/-4 vs T-bet
-/- =1 0 + / - 5 ;p <0 . 0 5) .T od e t e r m i n e
whether T-bet inhibits the development of Th17 cells dur-
ing HP we measured the level of Th17 cells in the lungs
with 3 weeks of S. rectivirgula exposure by intracellular
cytokine staining (Figure 3A). There were almost no Th17
cells (0.4%) in the lungs of WT mice exposed to saline
that responded to ex vivo S. rectivirgula stimulation,
whereas WT mice that were exposed to S. rectivirgula had
approximately 7% of Th17 cells in the lungs. In contrast,
16% of CD4
+ T cells from T-bet
-/- mice expressed intracel-
lular IL-17 following stimulation with S. rectivirgula.W e
did not detect IFNg by intracellular cytokine staining in T
cells from exposed WT mice in response to ex vivo S. rec-
tivirgula stimulation. However, there were approximately
3% IFNg
+/CD4
+ T cells following PMA and ionomycin sti-
mulation suggesting there are some Th1 cells in the lungs
(data not shown). Real time PCR was performed to mea-
sure the level of IL-17 or IFNg mRNA in the lungs of WT
or T-bet
-/- mice and the results demonstrate a significant
increase in IL-17 mRNA in the T-bet
-/- mice compared to
t h eW Tm i c ee x p o s e dt oS. rectivirgula (Figure 3B).
Although there appeared to be a decrease in IFNg mRNA
expression in the T-bet
-/- mice compared to the WT mice
this was not statistically significant. The level of IL-17 pre-
sent in BALF from individual mice revealed that there was
also an increase in the level of IL-17 in the BALF from T-
bet
-/- mice exposed to S. rectivirgula (37+/-16 pg/ml) com-
pared to WT mice (17+/-16 pg/ml). Similar results were
observed in WT and T-bet
-/- mice exposed for 6 weeks
(data not shown). These results demonstrate that T-bet
Table 2 T-bet KO mice develop less severe alveolitis following long-term exposure to S. rectivirgula compared to WT
mice
Alveolitis
a PMN
b (%+/-SD) CD4 T cells
b (%+/-SD) CD8 T cells
b (% +/- SD) NK cells
b (% +/- SD)
WT Tbet
-/- WT Tbet
-/- WT Tbet
-/- WT Tbet
-/- WT Tbet
-/-
3w kS R 2.2 × 10
6+/-1.2 1.9 × 10
6+/-1.9 72+/-6.0 70+/-14 6+/-1.5 9+/-2.5 3+/-0.7 3+/-1.1 5+/-1.3 2+/-0.1
6w kS R 10.3 × 10
6+/-2.5 3.1 × 10
6 +/-2.2* 88+/-3.0 91+/-1 4+/-0.4 3+/-1.0 2+/-0.3 1+/-0.4 <1 <1
C57BL/6 or T bet
-/- mice (n = 5/group) were exposed to S. rectivirgula (150 μg) three times a week for three or six weeks.
a BAL was performed and the recovered cells were counted using trypan blue dye exclusion.
b Cells isolated from the BAL fluid were incubated with antibodies to various cell surface markers and analyzed by flow cytometry to determine the cellular
composition of the BALF. CD4
+ T cells were identified as bTcR
+/CD45
+/CD4
+; CD8
+ T cells - bTcR
+/CD45
+/CD8
+; PMNs - CD45
+/CD11b
+/Gr1
+; NK cells - CD45
+/NK1.1
+
*p < 0.05 compared to WT/S. rectivirgula group
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Figure 3 Increase in Th17 cells in T-bet KO mice following S.
rectivirgula exposure. C57BL/6 or T-bet-/- mice (5/group) were
intranasally exposed to S. rectivirgula (150 μg) or saline for 3 weeks.
Lungs were removed and cells were isolated from individual mice
as described in materials and methods. A) Lung cells were
stimulated overnight with S. rectivirgula or media alone prior to
intracellular cytokine staining. Lung cells from WT/saline exposed
mice were pooled due to the low number of CD4+ T cells in the
lungs of these mice. Cells were surface stained with antibodies to
CD45, bTcR chain and CD4 followed by permeabilization and
incubation with anti-IL-17 and IFNg antibodies and run on a BD
LSRII flow cytometer. The data was analyzed using DIVA software
and the % of cells expressing IL-17 or IFNg was obtained by gating
on CD45
+/bTcR
+/CD4
+ T cells. B) RNA was isolated from lungs of
individual mice, reverse transcribed, and real-time PCR performed
using primers specific for IFNg and IL-17 the results were normalized
to the housekeeping gene HPRT and expressed as fold induction
over unexposed mice. * p < 0.05; T-bet-/- mice exposed to S.
rectivirgula compared to WT mice exposed to S. rectivirgula.
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mine whether T-bet was required for granuloma forma-
tion, lungs from WT or T-bet
-/- mice were examined with
H&E staining (Figure 4C&D). The results demonstrate
that T-bet
-/- mice exposed to S. rectivirgula had granu-
loma formation which appeared to be increased compared
to that of WT mice. The increase in severity of granuloma
formation in the T-bet
-/- mice suggested that the disease
was more severe in these mice and subsequently we would
e x p e c tt os e ea ni n c r e a s ei nf i b r o s i s .T h e r e f o r ew em e a -
sured the collagen content in the lungs of mice exposed to
S. rectivirgula for 6 weeks (Figure 5). The results indicate
that there is a significant increase in the amount of col-
lagen from lungs of T-bet
-/- mice compared to the lungs
of WT mice. We did not detect an increase in IL-4 or IL-
13 mRNA in the T-bet
-/- mice compared to WT therefore
the increase in severity appears to be due to the increased
Th17 response and not a shift to a Th2 response (data not
shown). These results suggest that T-bet plays a protective
role in the disease by inhibiting the Th17 response, granu-
loma formation, and fibrosis.
Th17 cells are not absolutely required for granuloma
formation in HP
T cells are required for granuloma formation in HP and
although there is an increase in Th17 cells in the T-
bet
-/- mice which correlates with disease severity, it is
unclear whether Th17 cells are required for granuloma
formation. The differentiation of Th17 cells requires
TGFb and IL-6 during activation of naïve T cells and in
the absence of IL-6 Th17 cells do not differentiate. We
can detect increases in IL-6 in the BALF 18 hrs follow-
ing exposure with S. rectivirgula (saline = 3 +/- 4pg/ml
vs. S. rectivirgula = 1,180 +/- 163 pg/ml; p <0 . 0 5 ) .W e
also detected an increase in TGFb in the BALF of mice
exposed to S. rectivirgula (saline = 143 +/- 5 pg/ml vs.
S. rectivirgula =2 0 5+ / -2 6p g / m l ;p < 0.05). To inhibit
the development of Th17 cells during HP we used mice
deficient in IL-6 and exposed them to S. rectivirgula for
3 weeks to measure the development of granulomas. IL-
6
-/- mice developed a similar degree of alveolitis com-
pared to WT mice with no significant differences in the
cellular composition of the alveolitis (data not shown).
There were changes in the cellular composition of the
infiltrating immune cells (defined by expression of
CD45) into the interstitial lung tissue (Table 3). IL-6
-/-
mice exposed to S. rectivirgula demonstrated a decrease
in the % of CD4+ T cells as compared to the WT mice
(IL-6
-/- = 11+/-2.6% CD4
+ T cells vs WT = 18+/-4%
CD4
+ T cells; p < 0.05) whereas, the CD8
+ Tc e l lp o p u -
lation did not differ between the two groups. There was
also a significant increase in the % of monocytes/
Figure 4 Development of granulomas in lungs of WT and KO
mice. Representative H & E stained lung sections from WT mice (A
and C), IL-6KO mice (B), and T-Bet KO mice (D), exposed to S.
rectivirgula for 3 weeks. IL-6 KO mice exposed to S. rectivirgula (B)
form granulomas similar to WT mice exposed to S. rectivirgula (A). T-
bet KO mice exposed to S. rectivirgula (D) demonstrated more
severe granuloma formation compared to WT mice exposed to S.
rectivirgula (C). (Original magnification × 63).
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Figure 5 Increased collagen in lungs of T-bet mice exposed to
S. rectivirgula . C57BL/6 or T-bet
-/- mice (5/group) were intranasally
exposed to S. rectivirgula (150 μg) or saline for 3 weeks. The right
lung lobe was removed from mice and the collagen content was
determined as described in methods. The results are expressed as
amount of collagen/right lung lobe and represent the average+/-
SD in each group of mice. *p < 0.05; T-bet KO mice exposed to S.
rectivirgula compared to WT mice exposed to S. rectivirgula.
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Page 6 of 11macrophages in the IL-6
-/- mice exposed to S. rectivir-
gula as compared to WT mice (IL-6
-/- =3 8+ / -3 . 9
mon/mac vs. WT = 19 +/- 2.6 mon/mac; p <0 . 0 5 ) .T o
determine whether Th1 cells migrated into the lungs
and confirm that IL-6 was necessary for Th17 cell devel-
opment in this model, intracellular cytokine staining was
performed on lung cells stimulated with PMA and iono-
mycin (Figure 6A). The results demonstrate that there is
a decrease in the % of Th17 cells as well as IFNg
+/IL-17
+ T cells in the lungs of IL-6
-/- mice following S. recti-
virgula exposure compared to WT mice. However, there
appeared to be a corresponding increase in the % of
IFNg
+/IL-17
- T cells (Th1 cells) in the IL-6
-/- mice com-
pared to WT mice. Although cells other than Th17 cells
c a na l s op r o d u c eI L - 1 7i nt h i sm o d e l ,t h el a c ko fT h 1 7
cells resulted in a decrease in IL-17A and IL-17F mRNA
in the lungs of IL-6
-/- mice exposed to S. rectivirgula
(Figure 6B). Despite the decrease in Th17 cells (and IL-
17 mRNA) in the lungs of IL-6
-/- mice, H&E staining of
lung sections indicated that there was still granuloma
formation in the lungs similar to WT mice, indicating
that Th1 cells are sufficient for granuloma formation
and Th17 cells are not absolutely required (Figure 4A &
B). These results suggest that while IL-6 plays an impor-
tant role in determining the balance of Th1 vs. Th17
cells in the disease, the development of a Th1 response
is sufficient for granuloma formation.
Discussion
Previous studies have demonstrated that IFNg is neces-
sary for the development of granulomas in HP and the
results from these studies demonstrate that the tran-
scription factor T-bet plays a critical role in controlling
the severity of HP. Our in vitro studies demonstrated
that IL-18 in combination with either IL-12 or IL-15 sti-
mulated production of IFNg from neutrophils, which we
had previously identified as a cell source of IFNg during
the innate response to S. rectivirgula [15]. The synergis-
tic actions of IL-18 with IL-12 or IL-15 may reflect the
effect of IL-18 on cytokine receptor expression by neu-
trophils or the need for binding of multiple transcription
factors to the IFNg gene. One of the transcription
factors activated by IL-18 is T-bet and our results show
that IFNg production induced by S. rectivirgula is com-
pletely dependent on T-bet. The results from these in
vitro studies led us to propose that both IL-18 and T-
bet would be required for IFNg production in vivo dur-
ing HP. Our results using IL-18
-/- mice revealed that in
the absence of IL-18, IFNg mRNA and protein were
reduced compared to WT mice during the innate
immune response to S. rectivirgula. These results sug-
gest that IL-18 plays a role in the induction of IFNg
during the innate response to S. rectivirgula, although it
is possible that other cytokines such as IL-12 also con-
tribute to IFNg production. IL-18 has been demon-
strated to stimulate IFNg production by stimulating
expression of T-bet, however, we could not detect dif-
ferences in the expression of T-bet mRNA in the IL-
18
-/- mice compared to WT exposed mice (data not
shown). A kinetic study of T-bet expression is needed to
determine the optimal time point to examine the effect
of IL-18 deficiency on its expression; the time points we
examined may be too long after an exposure. Also, it is
likely that other cytokines such as IL-12 also contribute
to T-bet expression in this model and therefore the
absence of IL-18 alone may not be sufficient to reveal a
decrease in its expression. IL-18 is important for indu-
cing a proinflammatory cascade and in addition to IFNg,
IL-17 mRNA was also decreased. Ruth et al [25] also
found a decrease in IL-17 when IL-18
-/- mice (in com-
parison to WT mice) were injected with zymosan in a
murine arthritis model and suggested that IL-18 may
also play a role in regulating Th17 responses. In our
model we cannot determine whether IL-18 directly
induces IL-17 or does so through the induction of other
cytokines. IL-17 is associated with strong neutrophil
responses and can induce the neutrophil chemokine
MIP-2. However, despite the decrease in IL-17mRNA
the level of alveolitis (and neutrophil recruitment) was
similar in the IL-18
-/- mice compared to WT mice
exposed to S. rectivirgula. Our previous studies demon-
strated that S. rectivirgula directly induces MIP-2 and
we did not detect a decrease in MIP-2 mRNA in the IL-
18
-/- mice compared to WT mice and therefore, at least
Table 3 Cellular composition of infiltrating immune cells in WT and IL-6
-/- mice following S. rectivirgula exposure
CD4
+ T cells
a (% +/- SD) CD8
+ T cells
b (% +/- SD) Mon/Mac
c (% +/- SD) NK cells
d (% +/- SD)
WT/S. rectivirgula 18 +/- 4.0 6 +/- 1.3 19 +/- 2.6 5 +/- 1
IL-6
-/- /S. rectivirgula 11 +/- 2.6* 6 +/- 1.8 38 +/- 3.9* 6 +/-0.9
C57BL/6 or IL-6
-/- mice (n = 5/group) were exposed to S. rectivirgula (150 μg) 3 times a week for three weeks and flow cytometry performed on lung cells
isolated from individual mice to determine the cellular composition of the infiltrating cells using antibody to various cell surface markers and run on a BD LSRII
flow cytometer. The data was analyzed using FACS DIVA software.
a CD4
+ T cells were identified as bTcR
+/CD45
+/CD4
+
b CD8
+ T cells were identified as bTcR
+/CD45
+/CD8
+
c Moncytes/macrophages were identified as CD45
+/CD11b
+/Gr1
-
d NK cells were identified as CD45
+/NK1.1
+
*p < 0.05 compared to WT/S. rectivirgula group
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Page 7 of 11during the innate immune response, IL-17 does not
appear to be necessary for neutrophil recruitment or
MIP-2 production. The effects of IL-18 signaling defi-
ciency were restricted to the innate immune response to
S. rectivirgula; longer exposures did not result in any
effects on several parameters of disease severity. IL-18
-/-
mice did not differ from WT mice exposed to S. recti-
virgula in the level of alveolitis, granuloma formation, or
cytokine production following 3 weeks of exposures.
These results suggest that IL-18 plays a role in IFNg
production (as well as IL-17 production) during the
innate response to S. rectivirgula, however IL-18 is dis-
pensable for IFNg production as well as granuloma for-
mation during later phases of the disease.
The production of IFNg following S. rectivirgula sti-
mulation in vitro is dependent on T-bet and our in vivo
results confirmed this. In the absence of T-bet, IFNg
mRNA expression in the lung and protein in the BALF
was reduced compared to WT mice during the innate
immune response. Surprisingly, IL-17 mRNA was also
reduced despite some reports suggesting that in the
absence of IFNg or T-bet, IL-17 levels increase [23,24].
Despite the decrease in IL-17, the levels of MIP-2
mRNA in the T-bet
-/- mice were similar to WT and IL-
18
-/- mice again suggesting that IL-17 isn’t contributing
to MIP-2 production early in the disease course. Sur-
prisingly, the T-bet
-/- mice exhibited decreased alveolitis
compared to the WT or IL-18
-/- mice during both the
early and late stages of the disease. The reason for this
is not clear however, T-bet controls the expression of
genes other than IFNg, including adhesion molecules
and chemokine receptors that may be involved in neu-
trophil recruitment in this model [26-28].
To determine the effect of T-bet on development of
granulomas and fibrosis, mice were exposed to S. recti-
virgula for longer time periods. Our results demon-
strated that T-bet was not required for CD4+ T cell
migration into the lung following exposure; however,
the expression of CXCR3 was significantly reduced on
CD4+ T cells from T-bet
-/- mice compared to WT
mice. T-bet binds to the CXCR3 promoter and directly
upregulates CXCR3 expression and therefore it is not
surprising to see a decrease in CXCR3
+ Tc e l l si nt h e
lungs of Tbet
-/- mice [27,28]. These results suggest that
CXCR3 expression is not required for the migration of
pathogenic T cells into the lung; studies are underway
to identify the chemokine(s)/chemokine receptors that
are responsible for Th17 cell recruitment into the lung
in this model. To determine the effects of T-bet on
IFNg production and the development of the Th17
response, we examined T-bet
-/- mice that had been
exposed to S. rectivirgula for 3 or 6 weeks. The results
demonstrated that T-bet
-/- mice did not develop Th1
cells, as expected, and the level of IFNg mRNA was
reduced, although not completely absent. Therefore,
during the later phases of the disease, IFNg production
also occurs via a T-bet-dependent pathway although
there may be a contribution by T-bet-independent path-
ways. T-bet
-/- mice had approximately double the % of
Th17 cells in the lung compared to WT mice exposed
      Unstimulated              PMA and Ionomycin
IL-17 
I
F
N
γ
        WT
IL-6KO
0.9%
0.2% 3.0%                      3.0%
19.2%
13%                        0.8%
2.6%
0.4%
0.8%
   % IFNγ +  %IL-17+            %IFNγ+/IL-17+
WT 3.6+/-1.0            14.4+/-3.8             2.1+/-1.0 
9.4+/-3.2      3.0+/-0.3                0.4+/-0.3
A
IL-17A
IL-17F
Actin
    Saline       WT         IL-6-/-
B
 
IL-6-/-
Figure 6 IL-6 is required for development of Th17 cells during
HP. C57BL/6 or IL-6
-/- mice (5/group) were intranasally exposed to
S. rectivirgula (150 μg) or saline for 3 weeks. Lungs were removed
and cells were isolated from individual mice as described in
materials and methods. A). Lung cells were stimulated with media
alone or PMA and ionomycin for 4 hrs prior to intracellular cytokine
staining. Cells were surface stained with antibodies to CD45, bTcR
chain and CD4 followed by permeabilization and incubation with
anti-IL-17 and IFNg antibodies and run on a BD LSRII flow
cytometer. The data was analyzed using DIVA software and the %
of cells expressing IL-17 or IFNg was obtained by gating on CD45
+/bTcR
+/CD4
+ T cells. B) RT-PCR was performed on RNA isolated
from one lung lobe from individual WT or IL-6
-/- mice (n = 4/group)
exposed to saline or S. rectivirgula using primers specific for IL-17A
and IL-17F. The housekeeping gene b-actin was used as an internal
control.
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Th17 cell development via IFNg production as well as
through RORgt repression [23,24,29]; however, IFNg
-/-
mice develop less severe disease following S. rectivirgula
exposure suggesting that the effects of T-bet cannot be
attributed to IFNg production [13]. We have not
detected significant differences in RORgte x p r e s s i o na t
the time points measured (data not shown) and studies
are currently underway to determine the mechanism by
which T-bet is suppressing Th17 development. The shift
to a stronger Th17 response in the lungs of exposed T-
bet
-/- mice correlated with an increase in granuloma for-
mation and total collagen content indicating a more
severe onset of fibrosis at 6 weeks of exposure. These
results are in agreement with studies by Simonian et al
[16] and Joshi et al [30] which suggested that Th17 cells
are associated with disease severity in HP. Exposure of
IL-17RA
-/- mice to S. rectivirgula resulted in decreased
inflammation and fibrosis compared to WT mice sug-
gesting a pivotal role for Th17 cells in the disease pro-
cess [16]. Although the role of IL-17 and its related
cytokines in fibrosis remain to be clarified, the correla-
tion between increased IL-17 and collagen content in
this model suggests that IL-17 may be a key player in
fibrosis in HP. Wilson et al [31] reported that IL-17A is
necessary for development of fibrosis in the murine
bleomycin model. IL-10 was an important regulator of
IL-17 in this model, IL-10
-/- mice have elevated IL-17A
and develop more severe fibrosis which was inhibited in
IL-10
-/-/IL-17
-/- double knockout mice. There was a
strong correlation with IL-1b expression and fibrosis in
both the IL-10
-/- and IL-10
-/-/IL-17
-/- mice exposed to
bleomcyin suggesting that IL-1b may play a role in IL-
17A dependent fibrosis. Simonian et al [32] demon-
strated, using a B. subtilis model of HP, that IL-22 pro-
duced by gδ T cells acts in a protective manner,
inhibiting CD4+ T cell migration into the lung and col-
lagen deposition. Further studies are needed to investi-
gate whether T-bet expression regulates IL-22 or IL-1b
production in this model.
Although the Th17 response was associated with more
severe disease, our results indicate that a Th1 response
is not protective and can also lead to granuloma forma-
tion in HP. Th17 cell differentiation requires IL-6 and
TGFb and our results indicate that both are present in
the lungs of mice exposed to S. rectivirgula.M i c et h a t
are deficient in IL-6 production develop a similar level
of alveolitis compared to WT mice however there were
differences in the cellular composition of the immune
cells recruited into the lung interstitium. Following
exposure to S. rectivirgula IL-6
-/- mice exhibited a
decrease in the percentage of CD4
+ Tc e l l sa n da n
increase in the percentage of monocytes/macrophages
compared to WT mice. It is difficult to determine if the
changes in the cellular composition in the IL-6
-/- mice
is due to the lack of IL-6 or the switch from a Th17
dominant response to a Th1 dominant response. The
IL-6
-/- mice had a significant decrease in Th17 cells and
an increase in Th1 cells in the lungs following S. recti-
virgula exposure compared to the WT mice which had
predominantly Th17 cells. The WT mice exposed to S.
rectivirgula had a population of IFNg
+/IL-17
+ T cells
following PMA and ionomycin stimulation which we
have consistently observed at several time points (data
not shown). However, this population does not appear
in response to ex vivo S. rectivirgula stimulation and the
role of these cells in HP is unknown. In other models
IL-17
+/IFNg
+ T cells have been suggested to play a role
in pathogenicity; using the EAE murine model of MS,
Murphy, et al. [33] demonstrated that these cells infil-
trate the brain prior to the development of symptoms.
Additionally, MOG specific T cells that were IL-17
+/IFNg
+ were able to activate microglia cells in vitro
resulting in production of TNFa,I L - 1 b, and IL-6 which
contribute to CNS inflammation. The decrease in Th17
cells in IL-6
-/- mice is expected to result in a decrease in
IL-17 production and that was reflected by a decrease in
IL-17A and IL-17F mRNA. However, other cells besides
abT cells make IL-17 in this model [34] and therefore
IL-17 production was not completely inhibited in the
IL-6
-/- mice. The results demonstrate that IL-6 is neces-
sary for the development of a Th17 response in HP and
IL-6 is critical in determining the balance between a
Th1 and Th17 response. Although it has been reported
that IL-6
-/- mice have an increase in Treg activity [35]
w ed i dn o ts e ee v i d e n c eo fa ni n c r e a s ei nT r e g si no u r
model. The S. rectivirgula exposed IL-6
-/- mice had
similar levels of alveolitis and granuloma formation as
well as an increase in IFNg
+ T cells compared to the
WT mice. The decrease in Th17 cells was accompanied
by an increase in the percentage of Th1 cells in the
lungs and H&E staining revealed granuloma formation
in the lungs of the IL-6
-/- mice demonstrating that a
Th1 response will also result in pathology and that
Th17 cells are not absolutely required for granuloma
formation. Numerous experimental models have demon-
strated that Th1 and Th17 cells co-exist during disease
and even co-localize to areas of pathology suggesting
that the cells may interact or regulate each other in still
unknown ways [23,36,37]. Although the prevailing
thought has been that Th17 cells are mediating pathol-
ogy in some of these diseases it is becoming apparent
that in some cases both Th1 and Th17 cells may cause
disease. For example, Luger et al [38] demonstrated that
the murine model of autoimmune uveitis (EAU) can be
mediated by either Th1 or Th17 cells. Additionally, EAE
was induced in naïve mice by transfer of antigen specific
T cells modulated in vitro by IL-12 or IL-23 [39]. The T
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Page 9 of 11cells cultured in the presence of IL-12 demonstrated a
Th1 phenotype and upon transfer into naïve mice
induced EAE with CNS infiltrates consisting predomi-
nantly of monocytes and lymphocytes with few neutro-
phils. Whereas IL-23 cultured T cells retained a Th17
phenotype upon transfer into naïve mice and induced a
neutrophil rich CNS infiltrate. Intriguingly, the two
forms of EAE responded differently to anti-GM-CSF
therapy; EAE was suppressed in mice receiving IL-23-
modulated T cells but not in mice receiving IL-12-
modulated T cells [39]. Similarly, pathology in HP may
develop in the presence of either a Th1 or Th17
response and the balance between the two types of cells
may explain why some patients develop more severe
fibrotic disease. Furthermore, as in the EAE model,
there may be significant differences in the response to
treatment between a Th1 dominant HP pathology and a
Th17 dominant pathology.
The results from these studies demonstrate that T-bet
plays a critical role during the development of HP. Dur-
ing the innate immune response to S. rectivirgula, T-bet
regulates IFNg and IL-17 production contributing to the
severity of alveolitis. However, during the later phases of
the disease T-bet plays a protective role by regulating
development of the Th17 response, granuloma forma-
tion and fibrosis. The results suggest that the protective
effect of T-bet is due to inhibition of the Th17 response
and is not mediated by the development of Th1 cells;
shifting the response to a predominant Th1 response
also resulted in lung pathology. HP is a complex disease
which may not be easily categorized as a Th1 - or Th17
- mediated disease. Identifying factors and subsequently
the mechanisms by which they regulate these responses
may lead to the identification of targets for therapeutic
purposes.
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